[HTML][HTML] TGF-β signaling in health and disease
J Massagué, D Sheppard - Cell, 2023 - cell.com
The TGF-β regulatory system plays crucial roles in the preservation of organismal integrity.
TGF-β signaling controls metazoan embryo development, tissue homeostasis, and injury …
TGF-β signaling controls metazoan embryo development, tissue homeostasis, and injury …
Colorectal liver metastasis: molecular mechanism and interventional therapy
H Zhou, Z Liu, Y Wang, X Wen, EH Amador… - Signal transduction and …, 2022 - nature.com
Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …
Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis
R Jackstadt, SR van Hooff, JD Leach, X Cortes-Lavaud… - Cancer cell, 2019 - cell.com
The metastatic process of colorectal cancer (CRC) is not fully understood and effective
therapies are lacking. We show that activation of NOTCH1 signaling in the murine intestinal …
therapies are lacking. We show that activation of NOTCH1 signaling in the murine intestinal …
[HTML][HTML] Metabolic pathways regulating colorectal cancer initiation and progression
S La Vecchia, C Sebastián - Seminars in cell & developmental biology, 2020 - Elsevier
Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Despite
recent advances in the molecular genetics of CRC, poor treatment outcomes highlight the …
recent advances in the molecular genetics of CRC, poor treatment outcomes highlight the …
[HTML][HTML] The role of miRNAs in colorectal cancer progression and chemoradiotherapy
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth
most deadly cancer worldwide. CRC accounts for approximately 10% of all new cancer …
most deadly cancer worldwide. CRC accounts for approximately 10% of all new cancer …
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
PW Eide, J Bruun, RA Lothe, A Sveen - Scientific reports, 2017 - nature.com
Colorectal cancers (CRCs) can be divided into four gene expression-based biologically
distinct consensus molecular subtypes (CMS). This classification provides a potential …
distinct consensus molecular subtypes (CMS). This classification provides a potential …
[HTML][HTML] Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
AE Overacre-Delgoffe, HJ Bumgarner, AR Cillo… - Immunity, 2021 - cell.com
The composition of the intestinal microbiota is associated with both the development of
tumors and the efficacy of anti-tumor immunity. Here, we examined the impact of microbiota …
tumors and the efficacy of anti-tumor immunity. Here, we examined the impact of microbiota …
TGF-β signaling in metastatic colorectal cancer (mCRC): from underlying mechanism to potential applications in clinical development
X Li, Y Wu, T Tian - International journal of molecular sciences, 2022 - mdpi.com
Colorectal cancer (CRC) is a serious public health issue, and it has the leading incidence
and mortality among malignant tumors worldwide. CRC patients with metastasis in the liver …
and mortality among malignant tumors worldwide. CRC patients with metastasis in the liver …
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
LH Che, JW Liu, JP Huo, R Luo, RM Xu, C He, YQ Li… - Cell discovery, 2021 - nature.com
Metastasis is the primary cause of cancer-related mortality in colorectal cancer (CRC)
patients. How to improve therapeutic options for patients with metastatic CRC is the core …
patients. How to improve therapeutic options for patients with metastatic CRC is the core …
KRAS oncogenic signaling extends beyond cancer cells to orchestrate the microenvironment
P Dias Carvalho, CF Guimaraes, AP Cardoso… - Cancer research, 2018 - AACR
KRAS is one of the most frequently mutated oncogenes in cancer, being a potent initiator of
tumorigenesis, a strong inductor of malignancy, and a predictive biomarker of response to …
tumorigenesis, a strong inductor of malignancy, and a predictive biomarker of response to …